334 related articles for article (PubMed ID: 22695769)
1. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time.
Samimi-Rad K; Nasiri Toosi M; Masoudi-Nejad A; Najafi A; Rahimnia R; Asgari F; Shabestari AN; Hassanpour G; Alavian SM; Asgari F
Arch Virol; 2012 Oct; 157(10):1959-65. PubMed ID: 22695769
[TBL] [Abstract][Full Text] [Related]
2. The effects of widespread methadone treatment on the molecular epidemiology of hepatitis C virus infection among injection drug users in Hong Kong.
Chan DP; Lee SS; Lee KC
J Med Virol; 2011 Jul; 83(7):1187-94. PubMed ID: 21567422
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus molecular epidemiology in Uzbekistan.
Kurbanov F; Tanaka Y; Sugauchi F; Kato H; Ruzibakiev R; Zalyalieva M; Yunusova Z; Mizokami M
J Med Virol; 2003 Mar; 69(3):367-75. PubMed ID: 12526047
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan.
Sanders-Buell E; Rutvisuttinunt W; Todd CS; Nasir A; Bradfield A; Lei E; Poltavee K; Savadsuk H; Kim JH; Scott PT; de Souza M; Tovanabutra S
J Med Virol; 2013 Jul; 85(7):1170-9. PubMed ID: 23918535
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
[TBL] [Abstract][Full Text] [Related]
6. Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.
Micalessi MI; Gérard C; Ameye L; Plasschaert S; Brochier B; Vranckx R
J Med Virol; 2008 Apr; 80(4):640-5. PubMed ID: 18297717
[TBL] [Abstract][Full Text] [Related]
7. Complex patterns of HCV epidemic in Suzhou: evidence for dual infection and HCV recombination in East China.
Du H; Qi Y; Hao F; Huang Y; Mao L; Ji S; Huang M; Qin C; Yan R; Zhu X; Zhang C
J Clin Virol; 2012 Jul; 54(3):207-12. PubMed ID: 22595306
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
[TBL] [Abstract][Full Text] [Related]
10. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
[TBL] [Abstract][Full Text] [Related]
11. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
[TBL] [Abstract][Full Text] [Related]
12. Changes in the prevalence of hepatitis C virus genotype among Italian injection drug users-relation to period of injection started.
Sereno S; Perinelli P; Laghi V
J Clin Virol; 2009 Aug; 45(4):354-7. PubMed ID: 19497783
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS
PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888
[TBL] [Abstract][Full Text] [Related]
14. Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies.
Oliveira ML; Yoshida CF; Telles PR; Hacker MA; Oliveira SA; Miguel JC; do O KM; Bastos FI
Epidemiol Infect; 2009 Jul; 137(7):970-9. PubMed ID: 19144250
[TBL] [Abstract][Full Text] [Related]
15. Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.
Aitken CK; Tracy SL; Revill P; Bharadwaj M; Bowden DS; Winter RJ; Hellard ME
J Clin Virol; 2008 Apr; 41(4):293-6. PubMed ID: 18242125
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus (HCV) 5'NC sequence variants and their association with hepatitis C risk groups.
Krekulova L; Rehak V; Riley LW
J Clin Virol; 2005 Apr; 32(4):300-4. PubMed ID: 15780809
[TBL] [Abstract][Full Text] [Related]
17. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
[TBL] [Abstract][Full Text] [Related]
18. Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy.
Dal Molin G; Ansaldi F; Biagi C; D'Agaro P; Comar M; Crocè L; Tiribelli C; Campello C
J Med Virol; 2002 Nov; 68(3):352-6. PubMed ID: 12226821
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.
Chlabicz S; Flisiak R; Kowalczuk O; Wiercińska-Drapalo A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L
J Med Virol; 2008 Apr; 80(4):615-8. PubMed ID: 18297715
[TBL] [Abstract][Full Text] [Related]
20. Changes in modes of hepatitis C infection acquisition and genotypes in southwest China.
Zhou Y; Wang X; Mao Q; Fan Y; Zhu Y; Zhang X; Lan L; Jiang L; Tan W
J Clin Virol; 2009 Nov; 46(3):230-3. PubMed ID: 19729342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
